StonvexLoading…
StonvexStonvexStonvexCore line items from TGTX's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $616.29M | $329.00M | $233.66M | $2.79M |
Operating Income | $123.32M | $41.93M | $20.63M | $-218.32M |
Net Income | $447.18M | $23.38M | $12.67M | $-223.81M |
EPS (Diluted) | $2.77 | $0.15 | $0.09 | $-1.65 |
Total Assets | $1.06B | $577.69M | $329.59M | $193.57M |
Total Liabilities | $415.23M | $355.33M | $169.09M | $134.99M |
Cash & Equivalents | $79.15M | $179.89M | $92.93M | $102.30M |
Free Cash Flow OCF − CapEx | $-24.99M | $-40.56M | $-31.41M | $-176.18M |
Shares Outstanding | 155.31M | 155.84M | 151.42M | 146.39M |